HRMY | Harmony Biosciences HoldingsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$37.02
-$0.89 (-2.35%)

Harmony Biosciences Holdings (HRMY) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, above both on the weekly and below both on the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $37.02 vs 50 $39.73 / 200 $34.70
Projection
No cross projected
Test
No active test
Last cross
Golden cross 1 Jul 2026 ยท projected 12 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $38.76 vs 50 $35.04 / 200 $34.21
Projection
No cross projected
Test
Active cross test, 1 bar at the 50, 4 bars left
Last cross
Golden cross week of 5 Oct 2026 ยท projected 11 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $37.86 vs 50 $38.44 / 200 $38.03
Projection
Death cross projected in 8 bars
Test
No active test
Last cross
Golden cross 10 Jun 2026 ยท projected 15 bars out

Cross history

27
crosses on record since 2021
15 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
week of 5 Oct 2026Golden moderateweekly11 bars outActive Cross Test
1 Jul 2026Golden steepdaily12 bars outNot tested
10 Jun 2026Golden4-hour15 bars outNot tested
18 Mar 2026Death steepdaily28 bars outNot tested
4 Mar 2026Death4-hour18 bars outNot tested

About HRMY

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$31.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.